We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.55B
Cap. Flow
% of AUM
-6.58%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$74.8M |
| 2 |
Sysco
SYY
|
+$54M |
| 3 |
ExxonMobil
XOM
|
+$42.4M |
| 4 |
Progressive
PGR
|
+$40.9M |
| 5 |
Mondelez International
MDLZ
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.68B |
| 2 |
Broadcom
AVGO
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Canadian Natural Resources
CNQ
|
+$77.6M |
| 5 |
Gilead Sciences
GILD
|
+$60.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
American Financial Group
AFG
$12B
| $925K | ﹤0.01% |
6,913
-160
| -2% | -$20.7K |
|
902
Veracyte
VCYT
$3.73B
| $920K | ﹤0.01% |
27,297
| – | – |
|
903
FMC
FMC
$1.3B
| $917K | ﹤0.01% |
14,073
+13,948
| +11,158% | +$854K |
|
904
Array Technologies
ARRY
$824M
| $916K | ﹤0.01% |
137,785
+113,313
| +463% | +$932K |
|
905
Commercial Metals
CMC
$7.97B
| $910K | ﹤0.01% |
16,594
| – | – |
|
906
ManpowerGroup
MAN
$2.62B
| $909K | ﹤0.01% |
12,438
| – | – |
|
907
NetEase
NTES
$81.9B
| $908K | ﹤0.01% |
9,200
| – | – |
|
908
Zai Lab
ZLAB
$2.92B
| $899K | ﹤0.01% |
36,648
+6,648
| +22% | +$126K |
|
909
Crown Holdings
CCK
$13.1B
| $894K | ﹤0.01% |
9,477
+183
| +2% | +$15.8K |
|
910
Texas Pacific Land
TPL
$25.2B
| $893K | ﹤0.01% |
3,042
-369
| -11% | -$101K |
|
911
Park Hotels & Resorts
PK
$2.89B
| $890K | ﹤0.01% |
61,374
+2,533
| +4% | +$36.9K |
|
912
PTC Therapeutics
PTCT
$6.15B
| $889K | ﹤0.01% |
24,000
-5,016
| -17% | -$168K |
|
913
Qfin Holdings
QFIN
$1.56B
| $876K | ﹤0.01% |
9,921
-10,094
| -50% | -$230K |
|
914
EQT Corp
EQT
$34B
| $875K | ﹤0.01% |
24,162
-2,491
| -9% | -$84.7K |
|
915
Encompass Health
EHC
$12.4B
| $872K | ﹤0.01% |
9,193
-468
| -5% | -$42.1K |
|
916
EPR Properties
EPR
$4.58B
| $864K | ﹤0.01% |
17,938
| – | – |
|
|
MPT
917
Medical Properties Trust
MPT
$2.4B
| $863K | ﹤0.01% |
143,910
+7,874
| +6% | +$38.8K |
|
918
Hyatt Hotels
H
$16.3B
| $857K | ﹤0.01% |
5,427
-677
| -11% | -$99.9K |
|
919
Ocular Therapeutix
OCUL
$2.14B
| $857K | ﹤0.01% |
100,000
| – | – |
|
920
Eagle Materials
EXP
$6.57B
| $841K | ﹤0.01% |
2,898
+823
| +40% | +$206K |
|
921
Interactive Brokers
IBKR
$40.7B
| $832K | ﹤0.01% |
24,172
| – | – |
|
922
GFL Environmental
GFL
$14.9B
| $827K | ﹤0.01% |
21,066
-531
| -2% | -$21.2K |
|
923
Celldex Therapeutics
CLDX
$3.48B
| $826K | ﹤0.01% |
25,000
| – | – |
|
924
SiriusXM
SIRI
$9.61B
| $826K | ﹤0.01% |
267,449
+263,487
| +6,650% | +$8.18M |
|
925
Broadstone Net Lease
BNL
$3.96B
| $818K | ﹤0.01% |
44,455
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2024 Portfolio in Review
As of Q3 2024, DekaBank Deutsche Girozentrale held 1,489 positions worth $53.9B, down 2.9% from $55.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $3.55B in Q3 2024, closing 60 positions and reducing 550 holdings. Its most notable exit was Labcorp, an estimated $36.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in SolarEdge worth $1.5M.
- DekaBank Deutsche Girozentrale's largest Q3 2024 buy was SolarEdge: 66,000 shares worth $1.5M.
- DekaBank Deutsche Girozentrale added most to CVS Health in Q3 2024, an estimated $74.8M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68B.
- DekaBank Deutsche Girozentrale fully exited Labcorp in Q3 2024, selling an estimated $36.3M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $53.9B portfolio in Q3 2024.
- DekaBank Deutsche Girozentrale opened 41 new positions and closed 60 in Q3 2024.
- DekaBank Deutsche Girozentrale's portfolio value fell 2.9% quarter-over-quarter to $53.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.